» Authors » M C Yoder

M C Yoder

Explore the profile of M C Yoder including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 1449
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen S, Gao R, Yao C, Kobayashi M, Liu S, Yoder M, et al.
Leukemia . 2017 Dec; 32(3):850-854. PMID: 29263439
No abstract available.
2.
Basile D, Collett J, Yoder M
Acta Physiol (Oxf) . 2017 Jun; 222(2). PMID: 28656611
Acute kidney injury (AKI) represents a significant clinical concern that is associated with high mortality rates and also represents a significant risk factor for the development of chronic kidney disease...
3.
Kobayashi M, Chen S, Bai Y, Yao C, Gao R, Sun X, et al.
Leukemia . 2017 Feb; 31(6):1453-1457. PMID: 28220038
No abstract available.
4.
Critser P, Voytik-Harbin S, Yoder M
Cell Prolif . 2011 Apr; 44 Suppl 1:15-21. PMID: 21481038
A great deal of attention has been recently focused on understanding the role that bone marrow-derived putative endothelial progenitor cells (EPC) may play in the process of neoangiogenesis. However, recent...
5.
Bailey J, Critser P, Whittington C, Kuske J, Yoder M, Voytik-Harbin S
Biopolymers . 2010 Aug; 95(2):77-93. PMID: 20740490
Elucidation of mechanisms underlying collagen fibril assembly and matrix-induced guidance of cell fate will contribute to the design and expanded use of this biopolymer for research and clinical applications. Here,...
6.
Critser P, Kreger S, Voytik-Harbin S, Yoder M
Microvasc Res . 2010 Mar; 80(1):23-30. PMID: 20219180
Developing tissue engineering approaches to generate functional vascular networks is important for improving treatments of peripheral and cardiovascular disease. Endothelial colony forming cells (ECFCs) are an endothelial progenitor cell (EPC)...
7.
Wu Y, Dai J, Schmuckler N, Bakdash N, Yoder M, Overall C, et al.
J Thromb Haemost . 2009 Oct; 8(1):185-93. PMID: 19874467
Background And Objective: Endothelial progenitor cells (EPCs) contribute to postnatal neovascularization, thus promoting wide interest in their therapeutic potential in vascular injury and prevention of their dysfunction in cardiovascular diseases....
8.
Sadat M, Dirscherl S, Sastry L, Dantzer J, Pech N, Griffin S, et al.
Gene Ther . 2009 Aug; 16(12):1452-64. PMID: 19657370
X-linked chronic granulomatous disease (X-CGD) is an inherited immunodeficiency with absent phagocyte NADPH-oxidase activity caused by defects in the gene-encoding gp91(phox). Here, we evaluated strategies for less intensive conditioning for...
9.
Yoder M
J Thromb Haemost . 2009 Jul; 7 Suppl 1:49-52. PMID: 19630767
There is no specific marker to identify an endothelial progenitor cell (EPC) and this deficiency is restricting the ability of an entire field of research in defining these cells. We...
10.
Prater D, Case J, Ingram D, Yoder M
Leukemia . 2007 Mar; 21(6):1141-9. PMID: 17392816
Since 1997, postnatal vasculogenesis has been purported to be an important mechanism for neoangiogenesis via bone marrow (BM)-derived circulating endothelial progenitor cells (EPCs). Based on this paradigm, EPCs have been...